• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酸治疗期间的肉碱缺乏症。

Carnitine deficiency during valproic acid treatment.

作者信息

Van Wouwe J P

机构信息

Department of Pediatrics, Drechtsteden Hospital Jacobus, Zwijndrecht, The Netherlands.

出版信息

Int J Vitam Nutr Res. 1995;65(3):211-4.

PMID:8830002
Abstract

Prolonged valproic acid treatment results in secondary carnitine deficiency. In thirteen children paired samples of plasma were drawn at the onset of, and after 9 months of continuous valproic acid treatment. At onset free plasma carnitine values were age dependent; they increased during childhood (r = 0.59, p = 0.016). After 9 months: 1 - mean plasma free carnitine decreased by 40%, from 32.7 mumol/l to 20.9 (p 0.0008 and 3% overlap; 2 - plasma total carnitine decreased by 20%, from 34.9 mumol/l to 27.1 (p 0.016 and no overlap); and 3 - the esterified/free carnitine ratio increased by 40%, from 0.28 to 0.39 (p 0.011 and no overlap). In two out of thirteen patients clinical symptoms were observed, fatigue, besides the biochemical evidence of carnitine deficiency. In four others only biochemical deficiency was found. If the child complains of fatigue during prolonged valproic acid treatment, it is advised to supplement carnitine. A dose of 15 mg/kg body weight is effective to reverse the clinical symptoms of carnitine deficiency within a week. The dose to prevent deficiency is not yet established.

摘要

长期使用丙戊酸治疗会导致继发性肉碱缺乏。对13名儿童在开始使用丙戊酸治疗时以及连续治疗9个月后采集配对的血浆样本。开始时,游离血浆肉碱值与年龄相关;在儿童期呈上升趋势(r = 0.59,p = 0.016)。9个月后:1 - 平均血浆游离肉碱下降40%,从32.7μmol/L降至20.9(p < 0.0008且重叠率为3%);2 - 血浆总肉碱下降20%,从34.9μmol/L降至27.1(p = 0.016且无重叠);3 - 酯化/游离肉碱比值上升40%,从0.28升至0.39(p = 0.011且无重叠)。13名患者中有2名除了有肉碱缺乏的生化证据外还出现了临床症状,即疲劳。另外4名患者仅发现生化缺乏。如果儿童在长期丙戊酸治疗期间诉说疲劳,建议补充肉碱。15mg/kg体重的剂量可在一周内有效逆转肉碱缺乏的临床症状。预防缺乏的剂量尚未确定。

相似文献

1
Carnitine deficiency during valproic acid treatment.丙戊酸治疗期间的肉碱缺乏症。
Int J Vitam Nutr Res. 1995;65(3):211-4.
2
The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.丙戊酸盐治疗的特发性癫痫患儿无症状高氨血症的风险:与血液肉碱状态的关系。
Epilepsy Res. 2009 Sep;86(1):32-41. doi: 10.1016/j.eplepsyres.2009.04.002. Epub 2009 May 14.
3
[Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].[评估长期丙戊酸治疗对小儿癫痫患者血浆中肉碱、氨及与尿素循环相关氨基酸水平的影响]
Rev Neurol. 1997 Jul;25(143):1037-44.
4
Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.接受新旧抗癫痫药物治疗且有或没有采用生酮饮食的癫痫儿童、青少年及年轻成年人的血浆游离肉碱水平
Brain Dev. 2006 Jul;28(6):358-65. doi: 10.1016/j.braindev.2005.11.005. Epub 2006 Jan 10.
5
L-carnitine replacement therapy in chronic valproate treatment.慢性丙戊酸盐治疗中的左旋肉碱替代疗法。
Neuropediatrics. 1990 Feb;21(1):40-3. doi: 10.1055/s-2008-1071456.
6
Carnitine does not improve weight loss outcomes in valproate-treated bipolar patients consuming an energy-restricted, low-fat diet.对于采用能量限制、低脂饮食的丙戊酸盐治疗的双相情感障碍患者,肉碱并不能改善其体重减轻的效果。
Bipolar Disord. 2006 Oct;8(5 Pt 1):503-7. doi: 10.1111/j.1399-5618.2006.00345.x.
7
Carnitine deficiency: Risk factors and incidence in children with epilepsy.肉碱缺乏症:癫痫患儿的危险因素及发病率
Brain Dev. 2015 Sep;37(8):790-6. doi: 10.1016/j.braindev.2014.12.004. Epub 2014 Dec 26.
8
Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.丙戊酸治疗期间的血清肉碱、β-羟基丁酸和氨水平
Turk J Pediatr. 1995 Jan-Mar;37(1):25-9.
9
Sodium valproate -- induced skeletal myopathy.丙戊酸钠所致骨骼肌病
Indian J Pediatr. 2005 Mar;72(3):243-4.
10
Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.接受丙戊酸治疗的儿童,无论是否联用其他抗惊厥药物,出现的肉碱缺乏和高氨血症。
Int J Clin Lab Res. 1999;29(1):36-40. doi: 10.1007/s005990050060.

引用本文的文献

1
Blood Levels of Ammonia and Carnitine in Patients Treated with Valproic Acid: A Meta-analysis.丙戊酸治疗患者的血氨和肉碱水平:一项荟萃分析。
Clin Psychopharmacol Neurosci. 2022 Aug 31;20(3):536-547. doi: 10.9758/cpn.2022.20.3.536.
2
Embryonic Hypotaurine Levels Contribute to Strain-Dependent Susceptibility in Mouse Models of Valproate-Induced Neural Tube Defects.胚胎型次牛磺酸水平与丙戊酸诱导的神经管缺陷小鼠模型中的品系依赖性易感性有关。
Front Cell Dev Biol. 2022 Feb 21;10:832492. doi: 10.3389/fcell.2022.832492. eCollection 2022.
3
Drug-Nutrition Interactions and the Brain: It's Not All in Your Head.
药物-营养相互作用与大脑:这不仅仅是头脑中的问题。
Curr Nutr Rep. 2019 Jun;8(2):92-98. doi: 10.1007/s13668-019-0273-2.
4
Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia.肉碱和/或乙酰肉碱缺乏作为血氨水平升高的一个原因。
Biomed Res Int. 2016;2016:2920108. doi: 10.1155/2016/2920108. Epub 2016 Feb 21.
5
Sodium valproate-induced myopathy in a child.丙戊酸钠诱发儿童肌病
Sultan Qaboos Univ Med J. 2015 Feb;15(1):e146-7. Epub 2015 Jan 21.
6
Drugs and pharmaceuticals: management of intoxication and antidotes.药物与药剂:中毒管理及解毒剂
EXS. 2010;100:397-460. doi: 10.1007/978-3-7643-8338-1_12.
7
Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid.肉碱转运体的识别与相互作用在新戊酸和丙戊酸诱导的左旋肉碱浓度降低中的作用。
Pharm Res. 2006 Aug;23(8):1729-35. doi: 10.1007/s11095-006-9002-9.
8
Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate.子宫内暴露于丙戊酸盐后的新生儿低血糖和戒断症状。
Arch Dis Child Fetal Neonatal Ed. 2000 Sep;83(2):F124-9. doi: 10.1136/fn.83.2.f124.